April 17, 2014

Package Inserts and Manufacturers for some US Licensed Vaccines

vaccine Syringe And Ampoules Package Inserts and Manufacturers for some US Licensed Vaccines

Click on Vaccine name for package insert (most are PDFs); click on name of Manufacturer for link.

Vaccine

Antigen(s)

Manufacturer

Latest Version

ActHIB

Haemophilus influenzae type b (PRP-T)

sanofi pasteur

Nov 2009

Adacel

Tetanus toxoid, reduced Diphtheria Toxoid, Acellular Pertussis Vaccine Adsorbed

sanofi pasteur

Feb 2012

Afluria

Influenza (2012-13 Formula)

CLS Limited

Apr 2012

Agriflu

Influenza (2012-13 Formula)

Novartis

July 2010

BayHep B 

Hepatitis B Immune Globulin (human)

Bayer

Mar 2004

BayRab

Rabies Immune Globulin

Bayer

Apr 1999

BayTet

Tetanus Immune Globulin (human)

Bayer

Mar 2004

BioThrax

Anthrax Vaccine Adsorbed

Emergent BioSolutions

May 2012

Boostrix

Tetanus toxoid, reduced Diphtheria Toxoid, Acellular Pertussis Vaccine Adsorbed

GlaxoSmithKline

Mar 2012
Cervarix

Human Papillomavirus (Types 16 and 18)

GlaxoSmithKline

Feb 2012

Comvax

Hepatitis B, Haemophilus influenza type b

Merck

Dec 2010

Daptacel

Diphtheria, Tetanus, (acellular) Pertussis

Aventis Pasteur

Jul 2011
DT Diphtheria and Tetanus Toxoids Adsorbed sanofi pasteur Dec 2005

Engerix-B

Hepatitis B

GlaxoSmithKline

July 2012

Fluarix

Influenza (2012-13 Formula)

GlaxoSmithKline

May 2012
Flucelvax Influenza (2012-13 Formula) Novartis Oct 2012
FluLaval Influenza (2012-13 Formula) GlaxoSmithKline May 2012

FluMist

Influenza (2012-13 Formula)

MedImmune

Jul 2012

Fluvirin

Influenza (2012-13 Formula)

Novartis

Jul 2012
Fluzone | High-Dose  |Intradermal

Influenza (2012-13 Formula)

sanofi pasteur

Jun 2012

Gardasil

Human Papillomavirus (Types 6, 11, 16, and 18)

Merck

Apr 2011

Havrix

Hepatitis A

GlaxoSmithKline

July 2012

Hiberix

Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) booster dose

GlaxoSmithKline

Mar 2012

Imogam Rabies

Rabies Immune Globulin

sanofi pasteur

Dec 2005

Imovax Rabies

Rabies Vaccine (HDCV)

sanofi pasteur

Dec 2005

Infanrix

Diphtheria, Tetanus, (acellular) Pertussis

GlaxoSmithKline

Jul 2012

IPOL

Polio (inactivated)

sanofi pasteur

Dec 2005

Ixiaro commercial |military

Japanese Encephalitis

Intercell Biomedical

Sep | Sep 2010

JE-VAX

Japanese Encephalitis

sanofi pasteur

Dec 2005

KINRIX

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus

GlaxoSmithKline

Jul 2012

Menactra

Meningococcal(Groups A,C, Y, W-135) Polysaccharide Diptheria Toxoid Conjugate

sanofi pasteur

Nov 2011

Menomune-A/C/Y/W-135

Meningococcal (polysaccharide) (Groups A,C, Y, W-135)

sanofi pasteur

May 2012

Menveo

Meningococcal (Groups A, C, Y and W-135) Novartis Mar 2011

M-M-R II

Measles, Mumps, Rubella (live)

Merck

Mar 2010

Nabi-HB

Hepatitis B Immune Globulin

NABI

Apr 2008

Pediarix

Diphtheria, Tetanus, Pertussis, Hepatitis B and Poliovirus

GlaxoSmithKline

Apr 2012

PedvaxHIB

Haemophilus influenzae type b (PRP-OMP)

Merck

Dec 2010

Pentacel

Diphtheria, Tetanus, Pertussis, Poliomyelitis, andHaemophilus influenzae type b

sanofi pasteur

Jul 2011

Pneumovax 23

Pneumococcal (polysaccharide)

Merck

Oct 2011

Prevnar

Pneumococcal 7-valent Conjugate Vaccine

Wyeth

Jul 2009

Prevnar-13

Pneumococcal 13-valent Conjugate Vaccine

Wyeth

Jan 2012

ProQuad

Measles, Mumps, Rubella and Varicella

Merck

Aug 2011

RabAvert

Rabies (PCEC)

Chiron

Oct 2006

Recombivax HB

Hepatitis B (recombinant)

Merck

Jul 2011

Rotarix

Rotavirus Vaccine, Live, Oral,

GlaxoSmithKline

Sep 2012

RotaTeq

Rotavirus Vaccine, Live, Oral, Pentavalent

Merck

Aug 2012
Td (generic) Tetanus and Diphtheria Toxoids Adsorbed Mass Biol Labs Apr 2009
Tenivac Tetanus and Diptheria Toxoids Adsorbed sanofi pasteur Dec 2010

TriHIBit

Diphtheria, Tetanus, (acellular) Pertussis, Hib

sanofi pasteur

Nov 2009

Twinrix

Hepatitis A and B

GlaxoSmithKline  

Jul 2012

Typhim Vi

Typhoid

Aventis Pasteur

Dec 2005

Vaqta

Hepatitis A (inactivated)

Merck

Jul 2012

Varivax

Varicella (live)

Merck

Aug 2011

Vivotif Berna

Typhoid

Berna

Aug 2006

YF-VAX

Yellow Fever

Aventis Pasteur Jan 2010

Zostavax

Varicella Zoster

Merck

Jun 2011

 

Reproduced with permission of the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

More vaccine package inserts here.

Vaccine Epidemic
by Louise Kuo Habakus and Mary Holland J.D.

Vaccine Epidemic bookcover Package Inserts and Manufacturers for some US Licensed Vaccines

 FREE Shipping Available!

More Info


0 commentsback to post

Other articlesgo to homepage

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

Congressman Bill Posey’s strong resolve and demands for transparency were evident as he discussed the Center for Disease Control (CDC)’s handling of vaccine safety studies which affect “our most precious resource in our nation – our children.” The 30-minute interview, conducted by vaccine industry watchdog, PhD biochemist Brian Hooker, delves into what Posey called “the incestuous relationship between the public health community and the vaccine makers and public officials.”

The Florida legislator, known as “Mr. Accountabililty,” did not mince words when criticizing current and past CDC officials including indicted fraudster Dr. Poul Thorsen; CDC director turned Merck Vaccine President Dr. Julie Gerberding; and the agency’s current spokesperson regarding autism and vaccines, Dr. Coleen Boyle.

Congressman Posey said, “The CDC can’t be trusted regarding investigating vaccine safety. Huge conflict of interest. I think the CDC should be investigated.”

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

In an interview with Dr. Bernard Dalbergue, a former pharmaceutical industry physician with Gardasil manufacturer Merck, he predicts that Gardasil will become the greatest medical scandal of all time. Dr. Dalbergue believes that at some point in time, the evidence will add up to prove that this vaccine, technical and scientific feat that it may be, has absolutely no effect on cervical cancer and that all the very many adverse effects which destroy lives and even kill young girls, serves no other purpose than to generate profit for the manufacturers.

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

An important new book by a recognized medical research expert describes Big Pharma as akin to the Mafia. In an interview conducted by our colleagues at ANH-Europe, Dr. Peter C. Gøtzsche exposes the flaws of the drug approval system, our reliance on dangerous drugs, and the deadly co-dependence between regulators and industry. Dr. Gøtzsche is co-founder of the highly respected Cochrane Collaboration and Cochrane Reviews, a leading journal of evidence-based medicine. The interview is particularly timely now that the FDA has decided to remove restrictions on the dangerous drug Avandia.

Dr. Gøtzsche’s new book, Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare, points out that the pharmaceutical industry is allowed to test their own drugs, and thus effectively be their own judge. He calls this a threat to safe medicine and asks for open access to all research data, including raw data, because otherwise, data can be easily suppressed and conclusions manipulated by industry.

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical marijuana, or cannabis, is legal in 20 US states, where it is used for a variety of medical conditions such as mood disorders, pain disorders, multiple sclerosis, and even cancer. Parents of children with epilepsy met at a news conference to share their dismay that Governor Mark Dayton refuses to legalize medical marijuana. About 85 percent to 95 percent of Americans are in favor of medical cannabis, and nearly 60 percent are in favor of legalizing marijuana. Cannabis shows outstanding promise as a medicinal plant, largely due to its cannabidiol (CBD) content. Cannabinoids interact with your body by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body.

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Pharmaceutical company payments to doctors extend far beyond rank-and-file clinicians — and deep into the leadership of America’s teaching hospitals, according to a study published recently in the Journal of the American Medical Association.

A team of researchers at the University of Pittsburgh Medical Center examined the boards of the 50 largest drug companies by global sales (excluding three companies that were not publicly traded). The researchers found that 40 percent — 19 companies — had at least one board member who also held a leadership role at an academic medical center. Sixteen of the 17 companies based in the United States had at least one. Several had more than one. All told, the research team found that 41 of the companies’ 2012 board members held leadership positions at academic medical centers. Six of the 41 were pharmaceutical company executives who served on hospital boards of directors or held other leadership posts.

The authors wrote that when academic medical leaders serve on pharmaceutical company boards, it can lead to conflicts not only for individuals, but for the critically important health care institutions they guide.

read more


Get the news right in your inbox!